Preclinical Alzheimer's disease criteria

The Lancet Neurology

Volumn 12, Issue 12, 2013, Pages 1134-

  Fagan, Anne M ^a   Vos, Stephanie J B ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN ISCHEMIA; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; DEMENTIA; DISEASE CLASSIFICATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; LETTER; MEDICAL INFORMATION SYSTEM; MEMORY; MILD COGNITIVE IMPAIRMENT; MOTOR DYSFUNCTION; PRIORITY JOURNAL; STAGING; DISEASE COURSE; FEMALE; MALE; PRODROMAL SYMPTOM;

ALZHEIMER DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PRODROMAL SYMPTOMS;

EID: 84887610712     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70222-9     Document Type: Letter

References (3)

1. Petersen RC Do preclinical Alzheimer's disease criteria work?. Lancet Neurol 2013, published online Sept 4. http://dx.doi.org/10.1016/S1474-4422(13)70217-5.
2. Vos SJB, Xiong C, Visser PJ, et al. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. Lancet Neurol 2013, published online Sept 4. http://dx.doi.org/10.1016/S1474-4422(13)70194-7.
3. Knopman DS, Jack CR, Wiste HJ, et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology 2012, 78:1576-1582.